Jump to content

20250177549. Muscle Targeting Compl (Dyne Therapeutics, .): Difference between revisions

From WikiPatents
Automated patent report
Automated patent report
 
Line 23: Line 23:


<!-- JSON-LD markup for search engines:
<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177549. Muscle Targeting Compl (Dyne Therapeutics, .)","name":"20250177549. Muscle Targeting Compl (Dyne Therapeutics, .)","description":"Patent application abstract and classification for 20250177549 - Muscle Targeting Compl","datePublished":"2025-06-10","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177549","name":"Muscle Targeting Compl","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Dyne Therapeutics, Inc."}]}}
{"@context":"https://schema.org","@type":"TechArticle","headline":"20250177549. Muscle Targeting Compl (Dyne Therapeutics, .)","name":"20250177549. Muscle Targeting Compl (Dyne Therapeutics, .)","description":"Patent application abstract and classification for 20250177549 - Muscle Targeting Compl","datePublished":"2025-06-11","mainEntity":{"@type":"GovernmentPermit","permitType":"Patent Application","identifier":"20250177549","name":"Muscle Targeting Compl","additionalProperty":[{"@type":"PropertyValue","name":"Organization","value":"Dyne Therapeutics, Inc."}]}}
-->
-->

Latest revision as of 03:43, 11 June 2025

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

Abstract: aspects of the disclosure relate to complexes comprising a muscle-targeting agent covalently linked to a molecular payload. in some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surface receptor on muscle cells. in some embodiments, the molecular payload promotes the expression or activity of a functional dystrophin protein. in some embodiments, the molecular payload is an oligonucleotide, such as an antisense oligonucleotide, e.g., an oligonucleotide that causes exon skipping in a mrna expressed from a mutant dmd allele.

Inventor(s): Romesh R. Subramanian, Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim

CPC Classification: A61K47/6807 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177549


Cookies help us deliver our services. By using our services, you agree to our use of cookies.